Suchergebnisse - "Vandebosch, An"

PubPharm (6)

1

Modifiers of COVID-19 vaccine efficacy : Results from four COVID-19 prevention network efficacy trials

enthalten in: Vaccine | 2023

von Turley, C. | Tables, L. | Fuller, T. | +33

2

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Hardt, K. | Vandebosch, A. | Sadoff, J. | +115

CommentIn: Lancet Infect Dis. 2022 Dec;22(12):1654-1655. - PMID 36113536

3

A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated

enthalten in: Annals of internal medicine | 2021

von Follmann, D. | Fintzi, J. | Fay, M. | +27

UpdateOf: medRxiv. 2020 Dec 14;:. - PMID 33336213

4

Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Reply

enthalten in: The New England journal of medicine | 2021

von Vandebosch, A. | Sadoff, J. | Douoguih, M.

CommentOn: N Engl J Med. 2021 Jul 15;385(3):288. - PMID 34107178

5

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

enthalten in: The New England journal of medicine | 2021

von Sadoff, J. | Gray, G. | Vandebosch, A. | +128

CommentIn: N Engl J Med. 2021 Jun 9;:. - PMID 34107178

6

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

enthalten in: Annals of internal medicine | 2021

von Mehrotra, D. | Janes, H. | Fleming, T. | +25

1
[1]